The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
Advisory on Small Space Ads
-
@Manufacturer and @Agency
NEW: PAAB Advisory – Small Space Ads
PAAB would like to thank everyone who collaborated with us on this project, for their time and expertise in the development of this advisory, including:
A cross-functional team from Brightworks
Ramy AinMelk, Digital Lead, GSK Canada
A cross-functional team from GSW
Andrew Leeson, Director of Client Services, Ogilvy Health
Jonathan Wasserman, M.B.A, Portfolio Marketing Lead, Pfizer Canada Oncology
Sylvain Messier, M.Sc, Senior Brand Manager, Pfizer Canada Rare Disease
Representatives from Tank WorldwideIf you have any questions about this advisory, please post below.